My Application Form Status

Check the status of your application form with Angel Broking.
  • Companies
  • Everything else
Search
Kalyani Steels hits the roof after strong Q1 outcome
Jul 25,2016

The result was announced during market hours today, 25 July 2016.

Meanwhile, the S&P BSE Sensex was up 260.11 points or 0.94% at 28,063.35

On BSE, so far 5.72 lakh shares were traded in the counter as against average daily volume of 52,192 shares in the past one quarter. The stock hit a high of Rs 226.90 in intraday trade so far, which is 52-week high for the counter. The stock hit a low of Rs 187.85 so far during the day. The stock had hit a 52-week low of Rs 117 on 21 October 2015. The stock had underperformed the market over the past one month till 22 July 2016, rising 1.78% compared with Sensexs 3.88% rise. The scrip, however, outperformed the market in past one quarter, advancing 9.24% as against Sensexs 7.61% rise.

The small-cap company has equity capital of Rs 21.83 crore. Face value per share is Rs 5.

Kalyani Steels is engaged in manufacturing and marketing iron and steel products.

Powered by Capital Market - Live News

GHCL surges after reporting strong Q1 results
Jul 25,2016

The result was announced during market hours today, 25 July 2016.

Meanwhile, the S&P BSE Senses was up 275.64 points or 0.99% at 28,079.81.

High volumes were witnessed on the counter. On BSE, so far 10.73 lakh shares were traded in the counter as against average daily volume of 1.54 lakh shares in the past one quarter. The stock hit a high of Rs 223.50, which was also a record high for the stock. The stock hit a low of Rs 204.90 so far during the day. The stock had hit a 52-week low of Rs 81.80 on 27 July 2015. The stock had outperformed the market over the past one month till 22 July 2016, gaining 14.34% compared with Sensexs 3.88% rise. The scrip had also outperformed the market in past one quarter, surging 48.76% as against Sensexs 7.61% rise.

The mid-cap company has equity capital of Rs 100.02 crore. Face value per share is Rs 10.

GHCL is a diversified company with an established foot print in chemistry and textiles segment.

Powered by Capital Market - Live News

Havells India scales record high after good Q1 result
Jul 25,2016

The result was announced on Saturday, 23 July 2016.

Meanwhile, the BSE Sensex was up 267.51 points, or 0.96%, to 28,070.75

On BSE, so far 2.88 lakh shares were traded in the counter, compared with an average volume of 1.07 lakh shares in the past one quarter. The stock hit a high of Rs 388.70 in intraday trade so far, which is record high for the counter. The stock hit a low of Rs 373.30 so far during the day. The stock hit a 52-week low of Rs 235.60 on 9 November 2015. The stock had underperformed the market over the past one month till 22 July 2016, rising 2.87% compared with Sensexs 3.88% rise. The scrip outperformed the market in past one quarter, advancing 11.36% as against Sensexs 7.61% rise.

The large-cap company has an equity capital of Rs 62.49 crore. Face value per share is Re 1.

Havells India is a fast moving electrical goods (FMEG) manufacturer, producing a wide range of industrial and consumer electrical products.

Powered by Capital Market - Live News

Volumes jump at KNR Constructions counter
Jul 25,2016

KNR Constructions clocked volume of 7.83 lakh shares by 14:00 IST on BSE, a 407.3-times surge over two-week average daily volume of 2,000 shares. The stock rose 0.13% at Rs 576.50.

Max India notched up volume of 9.27 lakh shares, a 43.55-fold surge over two-week average daily volume of 21,000 shares. The stock gained 1.72% at Rs 138.65.

Tata Motors DVR saw volume of 41.59 lakh shares, a 26.25-fold surge over two-week average daily volume of 1.58 lakh shares. The stock gained 0.35% at Rs 330.55.

Kalyani Steels clocked volume of 5.67 lakh shares, a 19.55-fold surge over two-week average daily volume of 29,000 shares. The stock surged 20% at Rs 226.90.

Kajaria Ceramics saw volume of 1.04 lakh shares, a 8.54-fold rise over two-week average daily volume of 12,000 shares. The stock rose 1.89% at Rs 1,251.10.

Powered by Capital Market - Live News

Sanofi India gains after reporting decent Q2 results
Jul 25,2016

The result was announced after market hours on Friday, 22 July 2016.

Meanwhile, the BSE Sensex was up 133.11 points, or 0.48%, to 27,936.35

On BSE, so far 1,039 shares were traded in the counter, compared with an average volume of 2,728 shares in the past one quarter. The stock hit a high of Rs 4,650 and a low of Rs 4,586 so far during the day. The stock had hit a record high of Rs 4,770 on 4 July 2016. The stock had hit a 52-week low of Rs 3,616 on 23 July 2015. The stock had outperformed the market over the past one month till 22 July 2016, rising 8.19% compared with Sensexs 3.88% rise. The scrip, however, underperformed the market in past one quarter, advancing 6.94% as against Sensexs 7.61% rise.

The large-cap pharma company has equity capital of Rs 23.03 crore. Face value per share is Rs 10.

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. In India, Sanofi operates through four entities - Sanofi India, Sanofi-Synthelabo (India), Sanofi Pasteur India, and Shantha Biotechnics.

Powered by Capital Market - Live News

Vivimed Labs gains after subsidiary divests certain products
Jul 25,2016

The announcement was made on Saturday, 23 July 2016.

Meanwhile, the S&P BSE Senses was up 127.12 points or 0.46% at 27,930.36.

On BSE, so far 38,254 shares were traded in the counter as against average daily volume of 41,866 shares in the past one quarter. The stock hit a high of Rs 80 and a low of Rs 76.35 so far during the day. The stock had hit a record high of Rs 97 on 12 January 2016. The stock had hit a 52-week low of Rs 46.94 on 25 August 2015. The stock had underperformed the market over the past one month till 22 July 2016, falling 2.8% compared with Sensexs 3.88% rise. The scrip had also underperformed the market in past one quarter, declining 11.7% as against Sensexs 7.61% rise.

The small-cap company has equity capital of Rs 16.20 crore. Face value per share is Rs 10.

Vivimed Labs said that as a part of the transaction, Klar Sehen will divest certain products within its portfolio to Ordain Healthcare Global Private Limited, a subsidiary of Spain based Chemo Espana S A. The total consideration for the identified product lines is Rs 73 crore. Further, Klar Sehen will provide contract manufacturing services for the divested products to Ordain Healthcare for an agreed period of time from its two plants located at Hyderabad and Kolkata.

Commenting on the development, Santosh Varalwar, Managing Director of Vivimed Labs said that as a part of the companys strategy, it has exited from the branded formulations in ophthalmology and will continue to focus on CMO and US generic business. Furthermore, the transaction will also provide the company enhanced financial flexibility by further reducing debt as company transitions into the next phase of growth.

On consolidated basis, Vivimed Labs net profit dropped 29.7% to Rs 12.61 crore on 2.5% drop in net sales to Rs 347.16 crore in Q4 March 2016 over Q4 March 2015.

Vivimed Labs is a leading manufacturer and exporter of specialty chemicals mainly used in the personal-care and pharmaceutical industries.

Powered by Capital Market - Live News

Thyrocare Technologies gains after good Q1 outcome
Jul 25,2016

The result was announced after market hours on Friday, 22 July 2016.

Meanwhile, the S&P BSE Sensex was up 132.11 points or 0.48% at 27,935.35

On BSE, so far 33,308 shares were traded in the counter as against average daily volume of 28,000 shares in the past two weeks. The stock hit a high of Rs 591 and a low of Rs 572.10 so far during the day. The stock had hit a record high of Rs 668.70 on 3 June 2016. The stock had hit a record low of Rs 523.60 on 24 June 2016. The stock had underperformed the market over the past one month till 22 July 2016, falling 0.66% compared with Sensexs 3.88% rise.

The mid-cap company has equity capital of Rs 53.72 crore. Face value per share is Rs 10.

Thyrocare Technologies is one of the leading pan-India diagnostic chain operators. It conducts an array of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases. The company primarily operates its testing services through a fully automated Central Processing Laboratory (CPL). It has recently expanded its operations to include a network of Regional Processing Laboratories (RPLs).

Powered by Capital Market - Live News

KSB Pumps drops after reporting weak Q2 results
Jul 25,2016

The result was announced after market hours on Friday, 22 July 2016.

Meanwhile, the S&P BSE Senses was up 121.70 points or 0.44% at 27,926.68.

On BSE, so far 1,661 shares were traded in the counter as against average daily volume of 2,844 shares in the past one quarter. The stock hit a high of Rs 726.70 and a low of Rs 694.50 so far during the day. The stock had hit a 52-week high of Rs 767.95 on 11 July 2016. The stock had hit a 52-week low of Rs 499 on 20 January 2016. The stock had outperformed the market over the past one month till 22 July 2016, gaining 10.88% compared with Sensexs 3.88% rise. The scrip had also outperformed the market in past one quarter, rising 18.49% as against Sensexs 7.61% rise.

The mid-cap company has equity capital of Rs 34.81 crore. Face value per share is Rs 10.

KSB Pumps manufactures pumps and valves. The company supplies its products to customers from industry and building services, OEMs, the energy industry, mining and the public sector, power plants, process engineering etc. KSBs products are also used in chemical, petrochemical and other industries to transport aggressive, corrosive, explosive, solids-laden and viscous liquids, industrial and municipal waste water and in the areas of heating and air conditioning.

Powered by Capital Market - Live News

Ahluwalia Contracts gains after securing orders
Jul 25,2016

The announcement was made during market hours today, 25 July 2016.

Meanwhile, the S&P BSE Senses was up 67.75 points or 0.23% at 27,867.52.

High volume was witnessed on the counter. On BSE, so far 8,541 shares were traded in the counter as against average daily volume of 2,699 shares in the past one quarter. The stock hit a high of Rs 301 and a low of Rs 292 so far during the day. The stock had hit a 52-week high of Rs 319.30 on 21 April 2016. The stock had hit a 52-week low of Rs 210 on 25 February 2016. The stock had outperformed the market over the past one month till 22 July 2016, gaining 4.17% compared with Sensexs 3.88% rise. The scrip had, however, underperformed the market in past one quarter, dropping 4.31% as against Sensexs 7.61% rise.

The mid-cap company has equity capital of Rs 13.40 crore. Face value per share is Rs 2.

Ahluwalia Contracts (India) said that orders are for construction of institutional, hospital and residential building including electrical, plumbing and firefighting services. The total order inflow during the year ending 31 March 2017 (FY 2017) stands at Rs 965.46 crore, it added.

The latest orders include construction of residential complex for National Cancer Institute at Jhajjar Haryana worth Rs 313 crore, construction of Regional Center for National Security Guard at Kolkata worth Rs 115.60 crore and civil, finishing and plumbing works for Tata Medical Centre at Kolkata worth Rs 44.21 crore.

Ahluwalia Contracts (India)s net profit rose 53.2% to Rs 26.71 crore on 22.1% rise in net sales to Rs 382.93 crore in Q4 March 2016 over Q4 March 2015.

Ahluwalia Contracts (India) is one of the leading civil contractors in India.

Powered by Capital Market - Live News

PSU oil stocks gain on merger reports for creating an oil sector giant
Jul 25,2016

Meanwhile, the S&P BSE Sensex was up 123.14 points or 0.44% at 27,926.38

Shares of state-run oil marketing companies (PSU OMCs) rose. BPCL (up 1.97%), HPCL (up 3.29%) and Indian Oil Corporation (up 3.85%) edged higher.

Stocks of state-run oil exploration and production firms rose. ONGC (up 1.15%) and Oil India (up 0.09%) edged higher. Shares of state-run gas transmission major GAIL (India) rose 0.49%. Among refiners, Mangalore Refinery and Petrochemicals (MRPL) surged 7.13%. Chennai Petroleum Corporation (CPCL) jumped 7.09%.

According to reports, the mega merger of 13 state-run oil firms will include ONGC, Oil India, GAIL (India), Indian Oil Corporation, BPCL, HPCL, GAIL (India), Mangalore Refinery and Petrochemicals (MRPL), Chennai Petroleum Corporation (CPCL) and Numaligarh Refinery. According to media reports, the government is also evaluating if the consolidated entity can include all non-corporate government bodies in the oil sector such as Oil Industry Development Board (OIDB), Petroleum Planning and Analysis Cell (PPAC) and Petroleum Conservation Research Association.

Meanwhile, in the global commodities markets, Brent for September settlement was currently down 5 cents at $45.64 a barrel. The contract had fallen 51 cents or 1.1% to settle at $45.69 a barrel during the previous trading session on Friday, 22 July 2016.

Powered by Capital Market - Live News

IL&FS Engineering jumps after winning Nagpur metro rail project
Jul 25,2016

The announcement was made after market hours on Friday, 22 July 2016.

Meanwhile, the S&P BSE Senses was up 19.89 points or 0.07% at 27,823.13.

High volumes were traded on the counter. On BSE, so far 97,735 shares were traded in the counter as against average daily volume of 13,188 shares in the past one quarter. The stock hit a high of Rs 58.60 and a low of Rs 55.60 so far during the day. The stock had hit a 52-week high of Rs 93.70 on 31 July 2015. The stock had hit a 52-week low of Rs 39.15 on 23 May 2016. The stock had outperformed the market over the past one month till 22 July 2016, gaining 16.21% compared with Sensexs 3.88% rise. The scrip had also outperformed the market in past one quarter, rising 8.07% as against Sensexs 7.61% rise.

The small-cap company has equity capital of Rs 121.16 crore. Face value per share is Rs 10.

IL&FS Engineering and Construction Company (IL&FS Engineering Services) received a Letter of Acceptance (LoA) from Nagpur Metro Rail Corporation, a joint venture of Government of India & Government of Maharashtra for Rs 532.67 crore Nagpur Metro Rail Project.

The project involves construction of seven elevated Metro stations, and three at-grade stations (North South Corridor). The project is to be completed in 110 weeks from the date of issue of LOA.

IL&FS Engineering Services is currently executing 4 Metro rail projects worth around Rs 1100 crore in Bangalore for Bangalore Metro Rail Corporation, in Gurgaon for Rapid Metro Rail Project, Phase-II (RMRG), in Kolkata for Rail Vikas Nigam Limited (RVNL), and in Ahmedabad for Metro-Link Express for Gandhinagar & Ahmedabad (MEGA) Company.

IL&FS Engineering and Construction Companys jumped 3767.1% to Rs 32.87 crore on 2% rise in net sales to Rs 589.08 crore in Q4 March 2016 over Q4 March 2015.

IL&FS Engineering and Construction Company is into infrastructure development, construction and project management.

Powered by Capital Market - Live News

Rallis India gains after declaring good Q1 result
Jul 25,2016

The result was announced after market hours on Friday, 22 July 2016.

Meanwhile, the S&P BSE Sensex was down 3.11 points or 0.01% at 27,800.13

On BSE, so far 1.48 lakh shares were traded in the counter as against average daily volume of 48,405 shares in the past one quarter. The stock hit a high of Rs 224.90 and a low of Rs 217.95 so far during the day. The stock had hit a 52-week high of Rs 258.90 on 23 July 2015. The stock had hit a 52-week low of Rs 142 on 21 January 2016. The stock had underperformed the market over the past one month till 22 July 2016, falling 4.1% compared with Sensexs 3.88% rise. The scrip, however, outperformed the market in past one quarter, advancing 7.89% as against Sensexs 7.61% rise.

The mid-cap company has equity capital of Rs 19.45 crore. Face value per share is Re 1.

Rallis Indias consolidated profit before tax (before exceptional items) rose 38% to Rs 62 crore in Q1 June 2016 over Q1 June 2015. The companys profit before tax surged 391.11% to Rs 221 crore in Q1 June 2016 over Q1 June 2015. The profit in Q1 June 2016 was boosted by an exceptional item of Rs 158 crore comprising profit on assignment of leasehold rights to a plot of land in the MIDC area, Turbhe, Navi Mumbai to Ikea India. The profit is net of costs including a premium levied under the repealed Urban Land (Ceiling and Regulation) Act 1976, which was paid under protest.

Rallis India is one of Indias leading agrochemicals companies.

Powered by Capital Market - Live News

Vedanta and Cairn India drop on profit booking after sweetening terms of merger deal
Jul 25,2016

Vedanta, Cairn India and the parent company, Vedanta Resources plc announced revised and final terms to the recommended merger between Vedanta and Cairn India after market hours on Friday, 22 July 2016.

Meanwhile, the S&P BSE Sensex was down 43.27 points or 0.16% at 27,759.97.

Vedanta (down 1.92% to Rs 165.70) and Cairn India (down 0.57% to Rs 190.90) declined.

Shares of Vedanta had surged 7.44% to Rs 168.95 on Friday, 22 July 2016 ahead of the announcement. Shares of Cairn India jumped 11.59% in four sessions to Rs 192 on 22 July 2016 from a low of Rs 172.05 on 18 July 2016,

The merger between Vedanta and Cairn India was announced on 14 June 2015. The boards of Vedanta and Cairn India approved revised and final terms for the transaction, taking into account prevailing market conditions and having regard to underlying commercial factors. Pursuant to the revised and final terms, each Cairn India minority shareholder will receive for each equity share held in Cairn one equity share in Vedanta and four redeemable preference shares with a face value of Rs 10 in Vedanta with a coupon of 7.5% and tenure of 18 months from issuance and implied premium of 20% to one month volume weighted average price (VWAP) of Cairn India share price. As per the original terms of the deal announced in June 2015, Cairn India shareholders were to get one equity share of Vedanta for each share held in the company and one 7.5% redeemable preference shares (RPS) of Vedanta of the face value of Rs 10 each with tenure of 18 months for each share held in Cairn India. The recent commodity price environment has further strengthened the strategic rationale for the merger, the two Vedanta group companies said in a joint statement.

The appointed date for the scheme has been revised to 1 April 2016 from 1 April 2015 earlier. The transaction is expected to close in the first quarter of calendar year 2017.

The transaction offers significant benefits for Cairn India shareholders such as de-risked earnings and stable cash flows supporting investment and dividends through the cycle, driving long term value, attractive transaction terms, exposure to Vedantas world class metals and mining assets, low cost, long life and well invested, delivering strong growth through production ramp ups, improved optionality to allocate capital and increased participation in cost savings, increased free float and trading liquidity and potential re-rating of the merged company.

The Jurisdictional High Courts have convened the shareholder meetings for Vedanta and Cairn India on 8 September 2016 and 12 September 2016 respectively. Following completion of the transaction, Vedanta plc ownership in Vedanta is expected to decrease to 50.1% from its current 62.9% shareholding. Cairn India minority shareholders will own 20.2% and Vedanta minority shareholders will own 29.7% stake in the merged entity.

Sudhir Mathur, CFO and Acting CEO of Cairn India said in a statement that Cairn India shareholders will benefit from exposure to a diversified portfolio of world-class, low cost, long-life assets of Vedanta. Tom Albanese, CEO of Vedanta said that the strategic rationale for merging Vedanta and Cairn India remains highly compelling. Diversified resources companies have delivered superior returns for shareholders historically, Albanese said.

Completion of the transaction will be conditional on receipt of the approvals of Vedanta and Cairn India shareholders, approvals at a High Court directed meetings scheduled for 8 September 2016 for Vedanta and 12 September 2016 for Cairn India, approval of Ministry of Petroleum & Natural Gas, approval of Jurisdictional High Courts where the registered offices of Vedanta and Cairn India are situated, Foreign Investment Promotion Boards approval and regulatory and other approvals as may be required.

Vedanta reported consolidated net loss of Rs 11181.26 crore in Q4 March 2016 compared with consolidated net loss of Rs 19228.12 crore in Q4 March 2015. Net sales fell 10.7% to Rs 15829.13 crore in Q4 March 2016 over Q4 March 2015.

Cairn Indias consolidated net profit fell 28.3% to Rs 359.55 crore on 28.2% fall in net sales to Rs 1885.11 crore in Q1 June 2016 over Q1 June 2015.

Powered by Capital Market - Live News

Cipla slips as Supreme Court asks company to deposit Rs 175.07 crore for drug overcharging
Jul 25,2016

The announcement was made after market hours on Friday, 22 July 2016.

Meanwhile, the S&P BSE Sensex was down 32.42 points or 0.12% at 27,770.82

On BSE, so far 12,472 shares were traded in the counter as against average daily volume of 1.87 lakh shares in the past one quarter. The stock hit a high of Rs 518 and low of Rs 513.40 so far during the day. The stock had hit a 52-week high of Rs 748 on 17 August 2015. The stock had hit a 52-week low of Rs 458.25 on 25 May 2016.

The large-cap company has equity capital of Rs 160.72 crore. Face value per share is Rs 2.

Cipla said that the writ petitions filed in the Bombay High Court that were pending before the Supreme Court have been retransferred to the Bombay High Court for a final hearing. The Supreme Court has directed the government to recover 50% of the overcharged amounts. Accordingly, the company is required to deposit Rs 175.07 crore within a period of six weeks. The interim order restraining the government from recovering the balance amount has been continued by the Supreme Court, the company said. The Bombay High Court will now hear these matters on merits, it added. Cipla made the announcement with reference to its earlier disclosures regarding pending legal cases relating to alleged overcharging in respect of certain drugs under the Drugs (Price Control), Order, 1995.

Ciplas consolidated net profit fell 68.9% to Rs 80.87 crore on 5.3% growth in total income to Rs 3321.28 crore in Q4 March 2016 over Q4 March 2015.

Cipla is a global pharmaceutical company. The companys portfolio includes over 1,500 products across wide range of therapeutic categories with one quality standard globally.

Powered by Capital Market - Live News

Axis Bank drops after poor Q1 result
Jul 25,2016

The result was announced after market hours on Friday, 22 July 2016.

Meanwhile, the S&P BSE Sensex was down 46.51 points or 0.17% at 27,756.73

On BSE, so far 55,000 shares were traded in the counter as against average daily volume of 7.03 lakh shares in the past one quarter. The stock hit a high of Rs 524.70 and a low of Rs 515 so far during the day. The stock had hit a 52-week high of Rs 598.45 on 23 July 2015. The stock had hit a 52-week low of Rs 366.65 on 18 January 2016.

The large-cap private sector bank has equity capital of Rs 477.52 crore. Face value per share is Rs 2.

Axis Bank said that the fall in net profit was due to a sharp surge in provisions and contingencies. Provisions and contingencies jumped 88.73% to Rs 2117.17 crore in Q1 June 2016 over Q1 June 2015. On a sequential basis, provisions and contingencies surged 81.21%. The banks net interest income rose 11.36% to Rs 4516.92 crore in Q1 June 2016 over Q1 June 2015. The core operating profit rose 3.27% to Rs 3558.19 crore in Q1 June 2016 over Q1 June 2015. The figure of core operating profit is arrived at after deducing trading income from operating profit.

On absolute basis, Axis Banks gross non-performing assets (NPA) edged higher to Rs 9553.17 crore as on 30 June 2016 from Rs 6087.51 crore on 31 March 2016 and Rs 4251.18 crore as on 30 June 2015. The ratio of gross NPA to gross customer assets edged higher to 2.54% as on 30 June 2016 from 1.67% as on 31 March 2016 and 1.38% as on 30 June 2015. The ratio of net NPA to net customer assets edged higher to 1.08% as on 30 June 2016 from 0.7% as on 31 March 2016 and 0.48% as on 30 June 2015.

Axis Bank attributed increase gross and net NPA to slippages from its watch list loans. As on 30 June 2016, loans outstanding on the banks watch list reduced 10% over the previous quarter and stood at Rs 20295 crore. The reduction in the watch list primarily represents slippages to NPAs amounting to Rs 2680 crore, which comprises 92% of the total corporate credit slippages. The banks provision coverage ratio declined to 69% as on 30 June 2016 from 72% as on 31 March 2016.

The cumulative value of net restructured assets as on 30 June 2016 stood at Rs 7363 crore, constituting 1.99% of net customer assets, compared to Rs 8072 crore, constituting 2.25% of net customer assets as on 31 March 2016.

The banks advances grew 21% year-on-year (YOY) to Rs 3.44 lakh crore as on 30 June 2016. Retail advances grew 24% YOY and stood at Rs 1.43 lakh crore, constituting 41% of the net advances of the bank. Corporate credit grew 21% YOY and stood at Rs 1.58 lakh crore, constituting 46% of net advances. SME advances grew 13% YOY and stood at Rs 43611 crore as on 30 June 2016. Axis Bank said that the bank remains well capitalized to pursue growth opportunities.

Axis Bank is one of the biggest private sector banks in India.

Powered by Capital Market - Live News